Melissa Almond
Medical · Bethel, AKNPI 1770093304
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Viiv Healthcare Company at 29.0% of the total. Reporting peaked in 2021 at $2,055 and has fallen 97.9% since, to $43 in 2025.
Across 98 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$718
- Gilead$314
- Janssen Products, LP$243
- Johnson & Johnson$228
- GSK$220
- Novo Nordisk$132
- plus $620 from 13 others
What the payments were for
- Food & beverage$2,45499%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 23 | $718 |
| Gilead | 11 | $314 |
| Janssen Products, LP | 2 | $243 |
| Johnson & Johnson | 13 | $228 |
| GSK | 14 | $220 |
| Novo Nordisk | 3 | $132 |
| AstraZeneca | 4 | $96 |
| Eisai Inc. | 7 | $90 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $85 |
| Orexo US, Inc. | 2 | $71 |
| Theratechnologies Inc. | 4 | $64 |
| Merck | 2 | $47 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| EMD Serono, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Protega Pharmaceutials Inc | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,475 in reported general payments places this provider in the 80th percentile of 140 medical providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $11,813 |
| XareltoRivaroxaban | 11 | $8,324 |
| SynthroidLevothyroxine Sodium | 27 | $1,518 |
| Metoprolol Succinate | 54 | $799 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $726 |
| Atorvastatin Calcium | 89 | $645 |
| Rosuvastatin Calcium | 42 | $503 |
| Losartan Potassium | 35 | $435 |
| Lisinopril | 83 | $353 |
| Gabapentin | 28 | $291 |
| Tamsulosin Hcl | 22 | $284 |
| Omeprazole | 36 | $272 |
| Amlodipine Besylate | 59 | $255 |
| Ibuprofen | 26 | $162 |
| Doxazosin Mesylate | 12 | $130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $228 | $8,32411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 140 medical providers in Alaska.
Other medical in Bethel
- Marlo CasteloBethel$707
- Christina FroilandAnchorage$22K
- Richard BlakeWasilla$19K
- Christopher DietrichPalmer$17K
- Adrian GianiAnchorage$6K
- Matthew LoudonWasilla$6K
- Kathryn AlbertWasilla$5K
- Karen ClementWasilla$5K
- Ksenia SokolovaWasilla$4K
- Ivy WeaklandAnchorage$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.